Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07003113 · ClinicalTrials.gov registry record · NA

Ischemic Preconditioning in Osteoarthritis and Back Pain

A NA study of Low Back Pain and Knee Osteoarthritis, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT07003113 is a NA study of Low Back Pain and Knee Osteoarthritis that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 24 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07003113, a NA study of Low Back Pain and Knee Osteoarthritis, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

We are examining the use of restricted blood flow, through full occlusion, on a single thigh for 50 minutes (5 minutes on, 5 minutes off), completed every other day for 2 weeks to improve function in individuals with knee osteoarthritis and low back pain.

Interventions

  • DEVICE Ischemic Preconditioning
  • DEVICE Sham Intervention

Study Locations (1)

Illinois

  • Human and Sport Performance Lab - Chicago

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-09-12
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT07003113

The ClinicalTrials.gov registry entry for NCT07003113 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Ischemic Preconditioning is the first listed.

NCT07003113 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07003113 about?

NCT07003113 is a clinical study titled "Ischemic Preconditioning in Osteoarthritis and Back Pain". We are examining the use of restricted blood flow, through full occlusion, on a single thigh for 50 minutes (5 minutes on, 5 minutes off), completed every other day for 2 weeks to improve function in individuals with knee osteoarthritis and low back pain.

What is the current status of trial NCT07003113?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-09-12. Estimated completion is 2026-12-31.

What conditions does trial NCT07003113 study?

This clinical trial studies the following conditions: Low Back Pain, Knee Osteoarthritis.

What interventions are being tested in trial NCT07003113?

The interventions under investigation include: Ischemic Preconditioning (DEVICE), Sham Intervention (DEVICE).

Who is sponsoring clinical trial NCT07003113?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07003113 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.